Claritev Corp. (CTEV)
26.82
-0.08
(-0.30%)
USD |
NYSE |
Nov 13, 16:00
27.09
+0.27
(+1.01%)
After-Hours: 19:59
Claritev Enterprise Value : 5.171B for Nov. 13, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 13, 2026 | 5.171B |
| November 12, 2026 | 5.172B |
| November 11, 2026 | 5.195B |
| November 10, 2026 | 5.203B |
| November 09, 2026 | 5.123B |
| November 06, 2026 | 5.101B |
| November 05, 2026 | 5.059B |
| November 04, 2026 | 5.083B |
| November 03, 2026 | 5.072B |
| November 02, 2026 | 5.105B |
| October 30, 2026 | 5.123B |
| October 29, 2026 | 5.123B |
| October 28, 2026 | 5.106B |
| October 27, 2026 | 5.100B |
| October 26, 2026 | 5.081B |
| October 23, 2026 | 5.114B |
| October 22, 2026 | 5.114B |
| October 21, 2026 | 5.106B |
| October 20, 2026 | 5.096B |
| October 19, 2026 | 5.088B |
| October 16, 2026 | 5.091B |
| October 15, 2026 | 5.121B |
| October 14, 2026 | 5.122B |
| October 13, 2026 | 5.118B |
| October 12, 2026 | 5.129B |
| Date | Value |
|---|---|
| October 09, 2026 | 5.134B |
| October 08, 2026 | 5.129B |
| October 07, 2026 | 5.141B |
| October 06, 2026 | 5.125B |
| October 05, 2026 | 5.135B |
| October 02, 2026 | 5.118B |
| October 01, 2026 | 5.077B |
| September 30, 2026 | 5.075B |
| September 29, 2026 | 5.037B |
| September 28, 2026 | 5.051B |
| September 25, 2026 | 5.064B |
| September 24, 2026 | 5.066B |
| September 23, 2026 | 5.095B |
| September 22, 2026 | 5.170B |
| September 21, 2026 | 5.206B |
| September 18, 2026 | 5.193B |
| September 17, 2026 | 5.208B |
| September 16, 2026 | 5.239B |
| September 15, 2026 | 5.273B |
| September 14, 2026 | 5.288B |
| September 11, 2026 | 5.280B |
| September 10, 2026 | 5.293B |
| September 09, 2026 | 5.285B |
| September 08, 2026 | 5.309B |
| September 04, 2026 | 5.322B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| LataMed AI Corp. | 7.107M |
| SCWorx Corp. | -1.154M |
| Health Catalyst, Inc. | 51.76M |
| GoodRx Holdings, Inc. | 1.454B |
| iSpecimen, Inc. | -3.171M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -61.79M |
| Revenue (Quarterly) | 268.31M |
| Total Expenses (Quarterly) | 330.10M |
| EPS Diluted (Quarterly) | -3.64 |
| Gross Profit Margin (Quarterly) | 32.45% |
| Profit Margin (Quarterly) | -23.03% |
| Earnings Yield | -61.20% |
| Operating Earnings Yield | 11.64% |
| Normalized Earnings Yield | -61.17 |